Results 261 to 270 of about 399,367 (396)

CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy

VIEW, EarlyView.
Abstract Immuno‐oncology represents an emerging field that has significantly transformed tumor therapeutics, with immune cells serving as the cellular foundations of cancer immunotherapy. Due to its high efficiency and sensitivity, CRISPR/Cas9 genome editing is a highly promising technique for precise and rapid gene modification.
Yuhui Ma, Junxin Chen, Yuan Du, Zhihao Cao, Weizhi Ji, Yuyu Niu, Zebin Yang   +6 more
wiley   +1 more source

Impact of Tyrosine Kinase Inhibitors on Thyroid Function in Chronic Myeloid Leukemia: A Systematic Review. [PDF]

Cureus
Sardarova N, Patel T, Abugoukh TM, Kim D, Yousuf S, Hammoude M.   +5 more
europepmc   +1 more source

Single‐cell spatial transcriptomic sequencing and machine learning models uncover molecular mechanisms and diagnostic biomarkers of Peyronie's disease formation in rats

VIEW, EarlyView.
Peyronie's disease (PD) is a common male reproductive system disorder. The exact etiology of PD remains unclear. This study aimed to investigate molecular and cellular changes in PD using single‐cell spatial transcriptomics. Abstract Peyronie's disease (PD), commonly known as penile induration, is a prevalent male reproductive system disorder with ...
Keyuan Lou, Qiancheng Mao, Junpeng Chi, Jiankun Zhang, Hao Guo, Jitao Wu, Yuanshan Cui   +6 more
wiley   +1 more source

Albert Schweitzer, Chronic Myeloid Leukemia, and War.

Oncol Res Treat
Schalk E.
europepmc   +1 more source

Dysregulation of sphingolipid metabolism contributes to the pathogenesis of chronic myeloid leukemia. [PDF]

Cell Death Dis
Xie Y, Zeng Q, Chen Z, Song J, Wang F, Liu D, Sun X, Zhang Y, Huang Q.   +8 more
europepmc   +1 more source

Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants [PDF]

, 1996
V. Radhika, Sathiah Thennarasu, Nishighanda R. Naik, Ajay Kumar, Suresh H. Advani, A.N. Bhisey   +5 more
openalex   +1 more source

Interventional oncology in children: Where are we now?

Journal of Medical Imaging and Radiation Oncology, EarlyView.
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel, Fernando Gómez Muñoz   +1 more
wiley   +1 more source

Unlocking the Potential of Perillaldehyde: A Novel Mechanism for Chronic Myeloid Leukemia by Targeting HSP70. [PDF]

Molecules
Zhang M, Wang J, Jiang R, Liu M, Zhang W.   +4 more
europepmc   +1 more source

Relapse in Chronic Myeloid Leukemia after Bone Marrow Transplantation: Biomathematical Modeling as a New Approach to Understanding Pathogenesis [PDF]

, 1999
P.C. Vincent, L. Rutzen‐Loesevitz, Bernd Tibken, B Heinze, E. Hofer, Theodor M. Fliedner   +5 more
openalex   +1 more source

The Fortunes of Genomic Medicine: A Quarter Century of Promise

Annals of Human Genetics, EarlyView.
ABSTRACT Background The culmination of the Human Genome Project in the early 2000s came wreathed in promises of a revolution in medicine and healthcare. The ensuing quarter century has seen remarkable growth in genomic medicine, as well as notable shifts in the promissory rhetoric that accompanies it.
Steve Sturdy
wiley   +1 more source